Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) FCF Margin (2016 - 2025)

Historic FCF Margin for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to 27.58%.

  • Iradimed's FCF Margin fell 13700.0% to 27.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.32%, marking a year-over-year decrease of 66500.0%. This contributed to the annual value of 24.06% for FY2024, which is 148700.0% up from last year.
  • Latest data reveals that Iradimed reported FCF Margin of 27.58% as of Q3 2025, which was down 13700.0% from 25.04% recorded in Q2 2025.
  • Over the past 5 years, Iradimed's FCF Margin peaked at 35.29% during Q2 2021, and registered a low of 11.31% during Q1 2023.
  • In the last 5 years, Iradimed's FCF Margin had a median value of 20.52% in 2023 and averaged 18.69%.
  • In the last 5 years, Iradimed's FCF Margin plummeted by -242500bps in 2022 and then soared by 318400bps in 2024.
  • Iradimed's FCF Margin (Quarter) stood at 27.58% in 2021, then tumbled by -31bps to 19.01% in 2022, then rose by 2bps to 19.37% in 2023, then decreased by -15bps to 16.49% in 2024, then surged by 67bps to 27.58% in 2025.
  • Its last three reported values are 27.58% in Q3 2025, 25.04% for Q2 2025, and 3.05% during Q1 2025.